G2 Insider: Automated CSF Cell Counters Require Updated Reference Ranges

Utilization of automated systems to provide cerebrospinal fluid (CSF) cell counts warrants new reference ranges, according to a study published in the January issue of Clinical Biochemistry. The … [Read more...]

G2 Insider: Zinc Protoporphyrin May Be Effective Screen for Iron Deficiency in Infants

Zinc protoporphyrin (ZPP) may be a simple screening test for iron deficiency (ID) and iron deficiency anemia in infants and toddlers, according to a study published online Feb. 18 in JAMA Pediatrics. … [Read more...]

G2 Insider: Can Metal Ion Testing Predict a Higher Risk of Metal Hip Failure?

Two recent U.K. studies have found that elevated blood metal ion levels are an indicator of metal hip implant failure. However, the two studies disagree as to whether metal ion testing is appropriate … [Read more...]

G2 Insider: Value of Urine Cytology Questioned for Hematuria Investigation

Urine cytology is of little clinical value in detecting urothelial cancers and should not be used routinely for first-line investigations of hematuria, according to a study published in the April … [Read more...]

G2 Insider: Lactoferrin, Inter-Alpha Inhibitor Protein May Differentiate Bacterial Infections in Kids

Lactoferrin (LF) and inter-alpha inhibitor protein (IaIp) are being investigated as potential biomarkers for differentiating serious bacterial infections in hospitalized pediatric populations, … [Read more...]

G2 Insider: Urine Screening Alone Significantly Underestimates STIs

A study of high-risk, gay men found that urine screening alone misses a significant number of sexually transmitted infections, according to an abstract presented at the annual meeting of the Pediatric … [Read more...]

G2 Insider: Single Viral Activity Test May Be Inadequate Before Immunomodulatory Therapy

A single antibody measurement of viral activity for the JC virus may not be sufficient to assess risk for the often fatal disease progressive multifocal leukoencephalopathy (PML) in patients receiving … [Read more...]

G2 Insider: AHRQ Identifies 178 Available Genetic Tests for Common Cancers

The Agency for Healthcare Research and Quality (AHRQ; Rockville, Md.) recently released an updated technology assessment that identifies 178 commercially available genetic tests for common … [Read more...]

G2 Insider: Fear Not: Patients Can Handle Online Test Results, Study Finds

Concerns by physicians about the repercussions of increasing independent patient access to online laboratory reports may be unfounded. Patients who view their lab test results online overwhelmingly … [Read more...]

G2 Insider: Reducing Clinically Unnecessary CD4 Monitoring Yields Substantial Savings

Recent research has shown that CD4 monitoring may not be needed in clinically stable, virally suppressed HIV-infected patients, but new evidence goes further to show that there is potential for … [Read more...]